These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22150916)

  • 1. Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease.
    Taniai M; Hashimoto E; Tokushige K; Kodama K; Kogiso T; Torii N; Shiratori K
    Hepatol Res; 2012 Apr; 42(4):359-67. PubMed ID: 22150916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity.
    Calzadilla N; Zilberstein N; Hanscom M; Al Rashdan HT; Chacra W; Gill RK; Alrefai WA
    Dig Liver Dis; 2024 Jun; 56(6):923-931. PubMed ID: 37923598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is nutrient intake a gender-specific cause for enhanced susceptibility to alcohol-induced liver disease in women?
    Wagnerberger S; Schäfer C; Schwarz E; Bode C; Parlesak A
    Alcohol Alcohol; 2008; 43(1):9-14. PubMed ID: 18003723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease.
    Nielsen JK; Olafsson S; Bergmann OM; Runarsdottir V; Hansdottir I; Sigurdardottir R; Björnsson ES
    Scand J Gastroenterol; 2017; 52(6-7):762-767. PubMed ID: 28276826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
    Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
    Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease.
    Kodama K; Tokushige K; Hashimoto E; Taniai M; Shiratori K
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E247-52. PubMed ID: 23320802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for alcoholic liver disease in China.
    Lu XL; Luo JY; Tao M; Gen Y; Zhao P; Zhao HL; Zhang XD; Dong N
    World J Gastroenterol; 2004 Aug; 10(16):2423-6. PubMed ID: 15285035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic effect of alcohol intake on the development of fatty liver disease.
    Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
    J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
    Younossi Z; Henry L
    Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.
    Raff EJ; Kakati D; Bloomer JR; Shoreibah M; Rasheed K; Singal AK
    J Clin Transl Hepatol; 2015 Mar; 3(1):9-16. PubMed ID: 26356325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.
    Idalsoaga F; Kulkarni AV; Mousa OY; Arrese M; Arab JP
    Front Med (Lausanne); 2020; 7():448. PubMed ID: 32974366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of ethanol-induced liver damage.
    Monzoni A; Masutti F; Saccoccio G; Bellentani S; Tiribelli C; Giacca M
    Mol Med; 2001 Apr; 7(4):255-62. PubMed ID: 11471570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
    Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis and alcohol-related liver disease.
    Lackner C; Tiniakos D
    J Hepatol; 2019 Feb; 70(2):294-304. PubMed ID: 30658730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
    Siddiqui MS; Charlton M
    Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting.
    Said A; Williams J; Holden J; Remington P; Musat A; Lucey MR
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):928-34. PubMed ID: 15476157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.